Huandao Conditioning Application for Allergic Rhinitis Treatment
NCT06818526 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95
Last updated 2025-02-13
Summary
The goal of this clinical trial is to learn if the Huandao Conditioning Application works to treat allergic rhinitis in adults. It will also learn about the safety of this application. The main questions it aims to answer are:
Does the Huandao Conditioning Application improve allergic rhinitis symptoms as measured by the Rhinitis Control Assessment Test (RCAT) and nasal airway resistance tests? What medical problems do participants have when using the Huandao Conditioning Application?
Researchers will compare the therapeutic version of the application to a placebo version (a look-alike application that contains no therapeutic effect) to see if the Huandao Conditioning Application works to treat allergic rhinitis.
Participants will:
Use either the therapeutic or placebo version of the application daily for 1 week in Phase 1 Take a 2-week break with no application use Use the opposite version of the application daily for 1 week in Phase 2 Visit the clinic at the beginning and end of each phase for checkups and tests Complete symptom assessment questionnaires before each application use and 1-2 hours after use Be monitored for any adverse reactions throughout the study period
Conditions
- Allergic Rhinitis
Interventions
- DEVICE
-
Huandao Conditioning Application
Mobile Application Intervention: Huandao Conditioning App for Allergic Rhinitis Treatment Type: Software Application (Mobile App) Purpose: Energy balancing therapy based on traditional Chinese medicine meridian theory Application Method: Self-administered via smartphone Duration: 5-10 minutes per session
- DEVICE
-
Placebo Huandao Conditioning App
Mobile Application Intervention: Placebo Huandao Conditioning App for Allergic Rhinitis Treatment Type: Software Application (Mobile App) Purpose: Energy balancing therapy based on traditional Chinese medicine meridian theory Application Method: Self-administered via smartphone Duration: 5-10 minutes per session
Sponsors & Collaborators
-
Buddhist Tzu Chi General Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-01
- Primary Completion
- 2025-12-31
- Completion
- 2026-12-31
More Related Trials
-
The Use of Hydrogen Ion Water (Shan Shang Water) in the Treatment of Allergic Rhinitis
NCT06756243 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber
NCT01804400 ·Status: COMPLETED ·Phase: PHASE2
-
New Nasal Applicator / New Formulation - User Study
NCT00641979 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
NCT04176185 ·Status: TERMINATED ·Phase: PHASE3
-
Trial of Tian Jiu Therapy for Allergic Rhinitis
NCT02470845 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis
NCT06323304 ·Status: COMPLETED ·Phase: NA
-
Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis
NCT04088721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intratonsillar Immunotherapy for Allergic Rhinitis
NCT06523478 ·Status: RECRUITING ·Phase: NA
-
Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis
NCT07052097 ·Status: COMPLETED ·Phase: PHASE2
-
Assess the Efficacy and Safety of Rhinocort Aqua
NCT00641693 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanisms of Allergen Immunotherapy
NCT00001910 ·Status: COMPLETED
-
The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis
NCT00119015 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis
NCT05038202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
NCT06441812 ·Status: RECRUITING ·Phase: PHASE2
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
NCT05570383 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Multimodal Data-assisted Primary Screening for Allergic Rhinitis Based on Voice Recognition and Face Recognition
NCT06474923 ·Status: COMPLETED
-
Efficacy of SLITone in House Dust Mite Allergic Patients
NCT00633919 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis
NCT05470647 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis
NCT01231464 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis
NCT04002349 ·Status: UNKNOWN ·Phase: NA
-
the Relationship Between Allergic Rhinitis and the Risk of Symptom in Patients With Mild COVID-19
NCT05753241 ·Status: COMPLETED
-
The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis
NCT04976023 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.
NCT06028490 ·Status: UNKNOWN ·Phase: PHASE2